Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on The U.S. - Session 1

Trade challenges, opportunities, risk mitigation and comparative perspectives in the Life Sciences sector.

Hogan Lovells’ APAC Life Sciences and Health Care Webinar Series is designed primarily for APAC-based companies in the life sciences and health care industry and for international companies in the sector that have business or commercial interests in the APAC region.

Following our recent “Spotlight on Greater China” sessions, we are now delighted to invite you to sessions that focus on the swiftly evolving U.S. life sciences and health care sector. Hogan Lovells’ life sciences and health care lawyers will share key insights and highlight practical strategies to enable companies to navigate the complex rules and regulations in the U.S. and to maximize opportunities while mitigating risk.

We are delighted to invite you to the inaugural session of our “Spotlight on the U.S.” sessions within our APAC life sciences and health care webinar series on Thursday, 14 September 2023:

In this session, we will cover trade issues in the life sciences and health care sector, especially those relating to U.S. national security policy, as implemented through export control restrictions and inbound and outbound investment screening (issues relating to the U.S. Committee on Foreign Investment in the United States (“CFIUS”) and to the coming U.S. outbound investment screening regime). Understanding the benefits and risks of prospective trade-related actions in APAC and the U.S. from a practical, strategic and comparative perspective is a key component of leveraging opportunities to achieve commercial success.
In particular, we will address the following key topics:


  • Implications of CFIUS’s broad jurisdiction on the life sciences and health care sector
  • Impact of CFIUS's mandatory filing programs on life sciences and health care sector
  • Biotechnology and biomanufacturing in President Biden’s CFIUS executive order
  • Practical tips for navigating the CFIUS regime (from both the foreign investor and the U.S. company perspectives)

Outbound investment screening regime

  • Update on outbound investment screening executive order
  • Update on pending outbound investment screening legislation
  • Likely impact of outbound investment screening regime on U.S. investors and Asian life sciences and health care companies

Trade and Investment Landscape in APAC

  • Update on U.S. export controls and sanctions and their effects in APAC
  • Briefing on Chinese countermeasures, including the anti-espionage law
  • Update on the Indo-Pacific Economic Framework (“IPEF”) and other trade agreements in APAC
Future “Spotlight on the U.S.” sessions in this webinar series will cover corporate, IP, and regulatory matters, with a particular focus on commercialization in the U.S., the Hatch-Waxman Act, and the Inflation Reduction Act, as well as environmental, social, and governance (“ESG”) considerations.

If you have any questions, please submit them in advance and our speakers will seek to address them during the webinar.

We hope you can join us.


Back To Listing